Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from Germany

OBJECTIVE: To report pregnancy outcomes and disease activity (DA) in women with MS, neuromyelitis optica spectrum disorders (NMOSDs), and other neuroimmunologic diseases (ONID) after treatment with rituximab (RTX)/ocrelizumab (OCR) 12 months before or during pregnancy. METHODS: Data were collected i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kümpfel, Tania, Thiel, Sandra, Meinl, Ingrid, Ciplea, Andrea I., Bayas, Antonios, Hoffmann, Frank, Hofstadt-van Oy, Ulrich, Hoshi, Muna, Kluge, Jakob, Ringelstein, Marius, Aktas, Orhan, Stoppe, Muriel, Walter, Annette, Weber, Martin S., Ayzenberg, Ilya, Hellwig, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757754/
https://www.ncbi.nlm.nih.gov/pubmed/33334856
http://dx.doi.org/10.1212/NXI.0000000000000913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757754/
https://www.ncbi.nlm.nih.gov/pubmed/33334856
http://dx.doi.org/10.1212/NXI.0000000000000913

Ejemplares similares